A phase 2 multicenter, randomized, placebo-controlled, parallel group dose-ranging study to evaluate the safety and efficacy of topical NEOSH101 in the treatment of androgenetic alopecia in men

Trial Profile

A phase 2 multicenter, randomized, placebo-controlled, parallel group dose-ranging study to evaluate the safety and efficacy of topical NEOSH101 in the treatment of androgenetic alopecia in men

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs NEOSH 101 (Primary)
  • Indications Male pattern baldness
  • Focus Therapeutic Use
  • Sponsors Neosil
  • Most Recent Events

    • 10 Jan 2008 Status changed from recruiting to in progress.
    • 06 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top